CD274 and gastric cancer: The principal strength of this study lies in its focus on the long-term prognostic effects of NICT on resectable locally advanced GC, AEG, and EC, providing valuable insights into the potential benefits of adding PD-1/PD-L1 inhibitors to NCT.